Jiangsu Lanfeng Bio-chemical Co.,Ltd (SHE:002513)

SHE:002513 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	553.59	408.13	457.34	24	84.57	331.46
Cash & Short-Term Investments	553.59	408.13	457.34	24	84.57	331.46
Cash Growth	8.50%	-10.76%	1805.42%	-71.62%	-74.49%	18.21%
Accounts Receivable	539.3	432.97	532.28	97.86	78.67	53.53
Other Receivables	100.58	113.7	207.84	77.23	187.04	236.3
Receivables	639.88	546.67	740.12	182.4	272.79	294.04
Inventory	194.26	182.44	167.77	98.05	132.7	129.76
Prepaid Expenses	-	-	-	0.88	-	0.04
Other Current Assets	185.26	170.31	210.44	54.94	55.98	67.64
Total Current Assets	1,573	1,308	1,576	360.27	546.04	822.94
Property, Plant & Equipment	1,737	1,754	1,526	868.19	935.6	1,256
Long-Term Investments	9.1	9.1	8.89	7.44	4.89	3.56
Other Intangible Assets	63.68	61.74	58.58	43.59	46.86	49.46
Long-Term Accounts Receivable	-	-	-	-	-	42
Long-Term Deferred Tax Assets	207.47	205.82	126.77	96.52	170.16	119.2
Long-Term Deferred Charges	0.16	0.81	0.53	0	0.02	0.15
Other Long-Term Assets	80.99	79.71	90.84	95.21	20.31	18.1
Total Assets	3,671	3,419	3,400	1,476	1,728	2,311
Accounts Payable	1,470	1,334	1,213	543.16	631.68	629.1
Accrued Expenses	26.25	29.93	30.83	34.24	23.52	13.23
Short-Term Debt	151.82	169.15	212.64	117.7	97.02	172.32
Current Portion of Long-Term Debt	35.15	33.77	-	-	-	-
Current Portion of Leases	-	0.89	0.67	0.57	0.33	145.43
Current Income Taxes Payable	5.48	0.9	19.78	0.25	0.24	-
Current Unearned Revenue	103.57	143.61	126.28	52.4	57.86	33.85
Other Current Liabilities	817.51	620.37	914.37	288.6	234.59	140
Total Current Liabilities	2,609	2,333	2,517	1,037	1,045	1,134
Long-Term Debt	422.54	422.64	408.46	-	-	-
Long-Term Leases	9.68	9.93	0.47	0.13	0.29	-
Long-Term Unearned Revenue	224.89	208.23	114.11	6.16	8.96	13.41
Long-Term Deferred Tax Liabilities	2.17	2.17	2.12	2.21	2.62	0.04
Other Long-Term Liabilities	123.79	130.21	106.3	72.54	4.21	3.77
Total Liabilities	3,393	3,106	3,149	1,118	1,061	1,151
Common Stock	375.28	375.28	373.94	373.94	340.09	340.09
Additional Paid-In Capital	2,138	2,136	1,898	1,902	1,825	1,825
Retained Earnings	-2,426	-2,403	-2,151	-1,819	-1,498	-1,007
Treasury Stock	-78.75	-78.75	-101.55	-101.55	-	-
Comprehensive Income & Other	3.15	3.26	5.48	1.74	-0.25	1.83
Total Common Equity	12.53	32.54	25.22	357.59	666.64	1,160
Minority Interest	265.91	280.04	225.43	-0	-	-
Shareholders' Equity	278.45	312.58	250.66	357.59	666.64	1,160
Total Liabilities & Equity	3,671	3,419	3,400	1,476	1,728	2,311
Total Debt	619.19	636.37	622.24	118.4	97.64	317.75
Net Cash (Debt)	-65.6	-228.23	-164.9	-94.4	-13.07	13.71
Net Cash Per Share	-0.18	-0.62	-0.44	-0.25	-0.04	0.04
Filing Date Shares Outstanding	375.28	375.28	373.94	372.3	340.09	340.09
Total Common Shares Outstanding	375.28	375.28	373.94	372.3	340.09	340.09
Working Capital	-1,036	-1,026	-941.8	-676.64	-499.2	-310.99
Book Value Per Share	0.03	0.09	0.07	0.96	1.96	3.41
Tangible Book Value	-51.15	-29.2	-33.35	314	619.78	1,110
Tangible Book Value Per Share	-0.14	-0.08	-0.09	0.84	1.82	3.27
Buildings	-	1,278	866.63	667.45	686.42	766.14
Machinery	-	1,395	938.68	1,295	1,458	1,472
Construction In Progress	-	5.29	542.38	14.01	5.05	143.5

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.